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 27 
Summary 28 
Reasons for performing study: An increased incidence of metabolic disease in 29 
horses has led to heightened recognition of the pathological consequences of insulin 30 
resistance (IR). Laminitis, failure of the weight-bearing digital lamellae, is an 31 
important consequence. Altered trafficking of specialised glucose transporters 32 
(GLUTs) responsible for glucose uptake, are central to the dysregulation of glucose 33 
metabolism and may play a role in laminitis pathophysiology.  34 
Objectives: We hypothesised that prolonged hyperinsulinaemia alters the regulation 35 
of glucose transport in insulin-sensitive tissue and digital lamellae. Our objectives 36 
were to compare the relative protein expression of major GLUT isoforms in striated 37 
muscle and digital lamellae in healthy horses and during hyperinsulinaemia. 38 
Study design: Randomised, controlled study. 39 
Methods: Prolonged hyperinsulinaemia and lamellar damage were induced by a 40 
prolonged-euglycaemic hyperinsulinaemic clamp (p-EHC) or a prolonged-glucose 41 
infusion (p-GI) and results were compared to electrolyte-treated controls. GLUT 42 
protein expression was examined with immunoblotting.  43 
Results: Lamellar tissue contained more GLUT1 protein than skeletal muscle (p = 44 
0.002) and less GLUT4 than the heart (p = 0.037). During marked hyperinsulinaemia 45 
and acute laminitis (induced by the p-EHC), GLUT1 protein expression was 46 
decreased in skeletal muscle (p = 0.029) but unchanged in the lamellae, while novel 47 
GLUTs (8; 12) were increased in the lamellae (p = 0.03), but not skeletal muscle. 48 
However, moderate hyperinsulinaemia and subclinical laminitis (induced by the p-GI) 49 
did not cause differential GLUT protein expression in the lamellae vs. control horses.  50 
Conclusions: The results suggest that lamellar tissue functions independently of 51 
insulin and that IR may not be an essential component of laminitis aetiology. Marked 52 
differences in GLUT expression exist between insulin-sensitive and insulin-53 
independent tissues during metabolic dysfunction in horses. The different expression 54 
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profiles of novel GLUTs during acute and subclinical laminitis may be important to 55 
disease pathophysiology and require further investigation.  56 
 57 
Introduction 58 
 59 
Insulin resistance (IR), defined as failure of insulin to facilitate glucose uptake into 60 
insulin-sensitive tissues, is a central feature of Equine Metabolic Syndrome [1]. The 61 
hyperinsulinaemia associated with IR is a risk factor for the development of laminitis 62 
[2-4]. Laminitis is intensely painful, often irreversible and currently without an 63 
effective treatment or cure [5]. The pathogenesis of laminitis is incompletely 64 
understood, and studies on the regulation of glucose transport in the lamellae are 65 
scarce and have been conflicting [6-8]. 66 
 67 
The uptake of glucose from the blood stream into a target tissue is achieved via 68 
facilitated diffusion and mediated by a family of specialised proteins, the glucose 69 
transporters (GLUT). Currently, fourteen GLUT isoforms have been identified with 70 
many having tissue specific functions [9; 10]. Whereas GLUT1 is a basal transporter 71 
responsible for insulin-independent glucose uptake in many tissues, such as the brain, 72 
GLUT4 is the best characterised insulin-sensitive transporter and is highly expressed 73 
in insulin-sensitive tissues, such as striated muscle [9; 11]. More recently, efforts to 74 
better understand the intricacies of glucose transport mechanisms have focussed 75 
attention on lesser understood class III GLUTs [12; 13]. Class III GLUTs are 76 
characterised by a having a slightly different structure to Class I, which includes 77 
GLUTs 1 and 4. Currently, there is considerable debate as to whether GLUTs 8 and 78 
12, both class III transporters, are basal, insulin-dependent or multifunctional 79 
transporters and their function may vary between tissue types [10; 14; 15]. Recent 80 
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work has shown that while GLUT12 is located at the plasma membrane, GLUT8 may 81 
be an intracellular (endosomal and lysosomal membranes) transporter [14; 16]. The 82 
relatively wide tissue distribution of GLUT8 and 12 suggests that they may be 83 
important in regulating glucose transport, and thus may also be implicated in IR [9; 17; 84 
18]. However, their functions are not well established. Therefore, further elucidation 85 
of their role in metabolic dysfunction is warranted.  86 
 87 
The recent development of two reliable experimental models of induced 88 
hyperinsulinaemia and lamellar dysfunction has resulted in an unprecedented 89 
opportunity to study the intricate pathophysiologies of IR in horses [19; 20]. 90 
Understanding the expression pattern of several GLUT isoforms (including the most 91 
recently discovered ones) across striated muscle and digital lamellae during 92 
hyperinsulinaemia in the horse may highlight the existence of alternate modes of 93 
regulation of glucose transport in this species, and identify novel therapeutic avenues 94 
for managing equine IR and laminitis. 95 
 96 
We hypothesised that prolonged exogenous or endogenous hyperinsulinaemia alters 97 
the regulation of glucose transport in insulin-sensitive tissue and the lamellae of 98 
healthy horses. The first objective of this study was to compare the relative protein 99 
expression of major GLUT isoforms, including the novel GLUT8 and 12 isoforms, in 100 
striated muscle (the major site of glucose disposal) and digital lamellae of healthy 101 
horses. The second objective was to measure the protein expression of these GLUT 102 
isoforms in skeletal muscle and lamellae of horses with exogenous or endogenous 103 
hyperinsulinaemia, and compare this to matched, normo-glycaemic normo-104 
insulinaemic controls. 105 
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 106 
 107 
Materials and Methods 108 
 109 
Subjects  110 
 111 
Archived samples of striated muscle and lamellar tissue were obtained from healthy 112 
Standardbred horses, which were treated with either a prolonged-euglycaemic 113 
hyperinsulinaemic clamp (p-EHC; n = 4), a prolonged-glucose infusion (p-GI; n = 4) 114 
or a balanced electrolyte solution (n = 8), as previously described [20, 21]. Briefly, 115 
aseptic, extended-use intravenous catheters (Millipore, NSW) were placed in both 116 
jugular veins for infusions and sampling. The p-EHC was administered as a constant 117 
rate infusion of insulin (Humulin-R (Eli-Lily, NSW), 6 mIU/kg bwt/min) combined 118 
with a variable rate 50% dextrose infusion (Baxter, NSW,) to maintain euglycaemia 119 
(~5 mmol/L), until the onset of Obel grade 2 laminitis [20]. During the p-GI, 50% 120 
dextrose (0.68 mL/kg/h) was infused at a constant rate. Each treated horse was 121 
randomly matched to a control horse treated with a balanced electrolyte solution 122 
(Hartmanns (Baxter, NSW) for the same period as their matched pair (p-EHC group: 123 
46 ± 2.3 h, p-GI group: 48 h). The groups did not differ in age or bodyweight.  124 
 125 
 Sample collection  126 
 127 
Blood samples were obtained to measure blood glucose (1 mL) and serum insulin (10 128 
mL) concentration for all horses. Blood glucose was measured immediately with a 129 
glucometer (Accucheck-Go, Roche) validated for horses (ρc = 0.96) and serum was 130 
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stored at -80°C until analysed for insulin concentration with a validated 131 
radioimmunoassay (Coat-a-count, Siemens Healthcare Diagnostics, IL) [22].  132 
 133 
Horses were euthanased humanely at the completion of each infusion and cardiac (left 134 
ventricular) and skeletal (mid-gluteal) muscle and lamellar tissue was collected from 135 
horses treated with a p-EHC and their matched controls. Only lamellar tissue was 136 
collected from p-GI-treated horses and their controls. Lamellar tissue (5 mm3) was 137 
extracted from the dorsal mid-section of the left front hoof with a band saw and then 138 
dissected with a scalpel. All samples were immediately frozen in liquid nitrogen and 139 
transferred to -80°C until processed. The protein content of GLUT1, 4, 8 and 12 was 140 
compared across the three tissues collected in control horses. GLUT protein 141 
expression was examined in samples of skeletal muscle and lamellae following the p-142 
EHC and compared to matched controls. Lamellar tissue was examined for GLUT 143 
protein content in horses treated with the p-GI and matched controls. 144 
 145 
Protein extraction and quantification 146 
 147 
Crude membrane fractions and total protein lysates were extracted from each frozen 148 
tissue sample (50 mg) as previously described [7; 23]. Briefly, crude membranes were 149 
extracted in buffer (210 mM sucrose, 40 mM NaCl, 2 mM EGTA, 30 mM Hepes with 150 
a protease inhibitor cocktail) on ice (2 x 15 s).  Cells were lysed (1.2 M KCl) prior to 151 
ultra-centrifugation at 100,000 x g for 90 min at 4°C.  The pellet was retained and re-152 
suspended in buffer (1 mM EDTA, 10 mM Tris HCl containing 0.33% vol 16% SDS) 153 
prior to further centrifugation for 45 min at 3,000 x g (18°C). Total protein was 154 
extracted by homogenization in Triton-X-100 extraction buffer (1% Triton-X-100, 155 
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150 mM NaCl, 50 mM Tris HCl, with a protease inhibitor cocktail) and centrifugation 156 
for 20 min at 800 x g (18°C). Protein concentration was determined in triplicate with 157 
the bicinchoninic acid (BCA) protein assay kit (Pierce, IL) using bovine serum 158 
albumin (BSA) standards (intra-assay CV = 1.8%). Absorbance at 562 nm was 159 
measured on a microplate reader (BioTek, VT). 160 
 161 
Western immunoblotting 162 
 163 
Skeletal muscle and lamellar protein extracts were analysed for protein content in 164 
total lysates and crude membrane fractions by quantitative Western blotting, as 165 
previously described [23; 24]. Briefly, equal amounts of protein (25 µg) were 166 
resolved on a 12% SDS polyacrylamide gel and then electrophoretically transferred to 167 
a polyvinylidene fluoride membrane (Millipore, MA) with subsequent 168 
immunoblotting. Membranes were incubated with primary antibodies: rabbit 169 
polyclonal, anti-human GLUT4; 1:750 (AbD Serotec, NC), rabbit polyclonal, anti-170 
human GLUT1; 1:500 (Santa Cruz, CA), rabbit polyclonal, anti-human GLUT8; 171 
1:500 (Santa Cruz, CA), rabbit polyclonal, anti-rat GLUT12; 1:500 (Abcam, MA) 172 
either at room temperature for 1 h (GLUT4), or at 4°C for 16 h (GLUT1, 8, 12), 173 
followed by incubation with an appropriate secondary antibody (1 h at room 174 
temperature) conjugated to horseradish peroxidase. Protein content was assessed by 175 
enhanced chemiluminescence reaction (KPL, MD) and quantified using a Gel-Pro 176 
Analyzer blot scanning and analysis system (Media Cybernetics, MD). The GLUT4 177 
and 12 antibodies were previously validated for use in the horse [24]. The GLUT1 178 
and 8 antibodies were chosen based on protein sequence homology [25] to Equus 179 
caballus which was 93% and 90% respectively. All antibodies were subject to initial 180 
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optimisation studies and validated against a positive control. Equal protein loading 181 
was confirmed by measuring rabbit polyclonal, anti-canine calsequestrin (muscle; 182 
1:2500, Thermo Scientific, DE) or goat polyclonal, anti-human actin (lamellae; 183 
1:1000, Santa Cruz, CA) protein expression following immunoblotting, except when 184 
multiple tissues were present in a single blot. 185 
 186 
Data analyses 187 
 188 
After checking for normality, clinical chemistry data were analysed with repeated 189 
measures ANOVA. Comparison of GLUT protein content across tissue sites was 190 
analysed with a one-way ANOVA on ranks. GLUT expression between treatment 191 
groups was analysed with a Mann Whitney u-test. Band densitometry results were 192 
compared between treated and control horses with a Mann-Whitney u-test. All data 193 
are expressed as mean ± se or median (interquartile range) and significance was 194 
accepted at p < 0.05. Statistical analyses were performed using SigmaPlot v. 12.3. 195 
 196 
Results 197 
 198 
Infusions 199 
 200 
The p-EHC group maintained normo-glycaemia but rapidly became markedly 201 
hyperinsulinaemic (Fig. 1). The p-GI induced significant hyperglycaemia, which 202 
stimulated moderate endogenous hyperinsulinaemia (Fig. 1). In addition, the p-EHC 203 
and p-GI induced clinical and subclinical laminitis, respectively, , whereas none of the 204 
control horses became lame. Matched control horses did not experience any changes 205 
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in insulin or glucose concentrations during the infusion of the balanced electrolyte 206 
solution. One control horse (matched to a p-GI horse) developed pyrexia of unknown 207 
origin and thus was withdrawn from the experiment. 208 
 209 
Relative quantification of GLUT expression in healthy horses 210 
 211 
Since GLUT distribution across major metabolic tissues has not been reported in the 212 
equine species, GLUT protein content was measured in crude membrane-enriched 213 
fractions across tissue sites (lamellae, cardiac and skeletal muscle) in healthy horses. 214 
GLUT1 protein expression was significantly greater in the lamellae than in skeletal 215 
muscle (Fig. 2a). Conversely, lamellar GLUT4 protein was difficult to detect and 216 
expression was significantly less than was detected in the heart (Fig. 2b). Protein 217 
expression of GLUT8 and 12 was equally abundant across the tissues examined (Fig. 218 
2c, d). 219 
  220 
GLUT expression during the p-EHC 221 
 222 
a) Skeletal muscle 223 
Prolonged, marked hyperinsulinaemia resulted in decreased GLUT1 expression in the 224 
crude membrane protein fraction, when compared to the control group (Fig. 3a), 225 
without a change in total GLUT1 protein expression (data not shown). GLUT4 226 
expression did not differ between treated and control groups in either the crude 227 
membrane (Fig. 3b), or total protein extracts (data not shown). Protein expression did 228 
not differ between treated and control groups for GLUT8 or 12 at the membrane 229 
surface (Fig. 3c, d), or in total protein lysates (data not shown). 230 
 10 
 231 
b) Lamellae 232 
Expression of GLUT1 protein did not differ between p-EHC and control groups in 233 
crude membrane (Fig. 4a) or total protein extracts (data not shown). However, protein 234 
expression of both GLUT8 and 12 was increased (p = 0.03) in crude membrane 235 
extracts from p-EHC treated horses, compared to controls (Fig. 4b, c), without a 236 
change in total protein expression (data not shown). In contrast, protein expression of 237 
GLUT4 in lamellar crude membrane fractions was not detected in any group (Fig. 5a). 238 
While GLUT4 protein was detected in total lysates, expression did not differ between 239 
p-EHC treated and control groups (Fig 5b).  240 
 241 
GLUT expression during the p-GI 242 
 243 
Lamellar protein expression did not differ for GLUTs 1, 8 or 12 in crude membrane 244 
fractions (Fig. 6), or total lysates (data not shown), from horses treated with a p-GI, 245 
when compared to their matched controls. As for the p-EHC treated group, GLUT4 246 
was barely detected in crude membrane-enriched fractions (Fig. 7). However, total 247 
GLUT4 protein lysates did not differ between groups (Fig. 7). 248 
 249 
Discussion  250 
 251 
The existing understanding of the regulation of glucose transport during metabolic 252 
diseases in horses is limited and conflicting [6-8; 24; 26]. The current study 253 
investigated the regulation of glucose transport in insulin-sensitive and lamellar 254 
tissues from both healthy and hyperinsulinaemic horses and showed that GLUT1 255 
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protein content exceeds GLUT4 in lamellar tissue, but not in striated muscle, and that 256 
lamellar dysfunction is associated with differential regulation of novel GLUT 257 
isoforms.  258 
 259 
A comparison of the protein content of GLUT isoforms at the membrane surface of 260 
striated muscles and lamellar tissue in healthy horses has identified the predominance 261 
of key ubiquitous (1 and 4) and novel (8 and 12) GLUT isoforms in these important 262 
metabolic tissues and provides novel insights into the regulation of glucose transport 263 
in this species. For instance, equine cardiac GLUT4 content was greater than that of 264 
skeletal muscle, and this is consistent with reports that glucose utilisation is 265 
approximately four times greater in the myocardium than in either skeletal muscle or 266 
adipose tissue, despite its ability to utilise other metabolic substrates [27]. While prior 267 
immunostaining of GLUT4 in the digital lamellae produced inconclusive results, 268 
others reported that GLUT4 mRNA was either absent or barely detectable in coronary 269 
band and lamellae [6; 8]. Importantly, this is the first study to quantify protein 270 
expression of major GLUT isoforms in the digital lamellae. The detection of minimal 271 
GLUT4 protein in lamellar crude membrane fractions of healthy horses suggested that 272 
GLUT4 is not a predominant isoform in the lamellae, and confirms that reliance on 273 
insulin-stimulated glucose uptake in the foot is unlikely. In addition, GLUT1 protein 274 
was more abundant in the lamellae than striated muscle, suggesting that GLUT1, a 275 
basal transporter, is a dominant isoform in the lamellae, further confirming the 276 
insulin-independent nature of this structure [6; 28]. Indeed, our findings are consistent 277 
with current understanding of GLUT trafficking and expression in striated muscle and 278 
the epidermis in other species [29]. The finding of equally abundant protein 279 
expression of the novel GLUTs 8 and 12, in striated muscles and the lamellae not only 280 
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demonstrates their presence in these tissues in the horse, but may suggest that they 281 
play an important role in the regulation of glucose metabolism in the highly metabolic 282 
lamellar tissue. Further, both GLUT8 and 12 may prove to be important transporters 283 
in the lamellar structure, given that GLUT4 was barely detectable. 284 
 285 
Interestingly, prolonged exogenous and endogenous hyperinsulinaemia did not appear 286 
to affect GLUT4 protein content in skeletal muscle. Although negative results should 287 
be interpreted with caution because of the small sample size, this finding is supported 288 
by an earlier study that demonstrated that in vitro insulin stimulation did not affect 289 
GLUT4 translocation to the sarcolemma of healthy and IR horses [24]. Corroboration 290 
of this result in IR horses, and in larger sample populations, is desirable. In addition, 291 
the lack of a decrease in membrane-bound skeletal muscle GLUT4 expression after 48 292 
h of marked hyperinsulinaemia suggests that IR is not required for laminitis onset, and 293 
is consistent with the concept that excessive insulin may instead be directly 294 
pathogenic to the lamellar structure, or that other pathogenic pathways are involved 295 
[30; 31]. 296 
 297 
We further reported a down-regulation of GLUT1 content at the membrane surface in 298 
skeletal muscle after ~48 hours of a p-EHC, which suggests that GLUT1 responds 299 
dynamically to altered metabolic states in the horse. In contrast with our findings, 300 
Suagee et al (2011) found that GLUT1 gene expression was increased in the skeletal 301 
muscle following 6 hours of an insulin and glucose infusion (EHC). Taken together, it 302 
could be hypothesised that the down-regulation of active GLUT1 by ~48 hours of a p-303 
EHC is a compensatory response to the marked hyperinsulinaemia, and thus an 304 
attempt to prevent further glucose uptake in skeletal muscle, thereby protecting the 305 
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cells from glucotoxicity. Conversely, the failure of novel GLUT (8 and 12) protein 306 
expression in the skeletal muscle membrane to respond to the p-EHC, when compared 307 
to control horses, may suggest that they do not contribute significantly to the 308 
regulation of glucose transport in this insulin-sensitive tissue.  309 
 310 
Early theories on the pathogenesis of laminitis occurring in association with metabolic 311 
disease postulated that down-regulation of GLUT4 during IR led to failure of glucose 312 
uptake in this highly metabolic structure, with subsequent lamellar hypoglycaemia 313 
and collapse [32]. However, the absence of GLUT4 protein in lamellar crude 314 
membrane fractions of healthy horses, combined with the lack of alteration of GLUT4 315 
gene [7] and protein expression by the p-EHC, suggests that GLUT4 may play an 316 
insignificant role in glucose regulation of the lamellae. The failure of total lamellar 317 
GLUT4 concentration to respond to the infusions is not unexpected given that it is the 318 
cell-surface (active) GLUT4 content that is likely to change in response to treatment, 319 
thus indicating an increase in GLUT4 translocation, although the small sample size 320 
may also have been a factor. In agreement with our findings, examinations of lamellar 321 
GLUT4 gene expression in ponies with laminitis showed that GLUT4 was not a 322 
predominant isoform in the lamellae [6].  323 
 324 
Although our study confirmed that GLUT1 is the major isoform in the digital lamellae, 325 
its expression during laminitis has been reported to be variable. A prior 326 
immunohistochemical study demonstrated loss of lamellar GLUT1 during chronic 327 
laminitis [8], while lamellar GLUT1 gene expression was unaffected during 328 
experimentally-induced acute laminitis in ponies [6] and horses [7]. This latter finding 329 
was confirmed by protein analysis in the current study. In light of prior reports of 330 
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increased lamellar GLUT1 gene expression at the 24 hour time-point of 331 
hyperinsulinaemic laminitis development, these collective findings may indicate that 332 
GLUT1 expression declines over the time course of laminitis. Thus, increases in 333 
lamellar basal glucose uptake during disease onset could contribute to the 334 
pathogenesis of laminitis [7]. In contrast, horses in the p-GI group, which exhibited 335 
subclinical laminitis and a 5-fold lower serum insulin concentration, did not display 336 
altered lamellar GLUT expression, suggesting that GLUT1 regulation is a complex 337 
but important facet of hyperinsulinaemic laminitis pathophysiology. GLUT1 338 
transcription can be stimulated by mitogens [33]. Insulin is a powerful mitogen and 339 
thus may have contributed to the increased GLUT1 gene expression documented 340 
during the marked hyperinsulinaemia of the p-EHC, but not during the less marked 341 
hyperinsulinaemia of the p-GI. GLUT1 also promotes epidermal hyperplasia by 342 
increasing the proliferation of epidermal keratinocytes [34]. Given that epidermal 343 
basal cell proliferation is a key element of hyperinsulinaemic laminitis 344 
pathophysiology [31], GLUT1 may play a role in the progression of lamellar 345 
attenuation and weakening.  346 
 347 
The fact that GLUTs 8 and 12 were differentially expressed between p-EHC-treated 348 
and control horses may suggest that these novel transporters play a role in laminitis 349 
pathophysiology. It appears that GLUT12 is able to sustain increased glucose 350 
consumption in human neoplastic conditions, including prostate carcinoma and breast 351 
cancer [35; 36]. Potentially, the unusually high glucose consumption rate of the hoof 352 
[28] has resulted in GLUT12 being constitutively expressed in this metabolically 353 
active tissue. It is also feasible that lamellar metabolic demand increases during 354 
disease states, such as laminitis, when rates of cell proliferation are increased, and this 355 
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may contribute to increased lamellar expression of GLUT12 during laminitis.  In 356 
addition to being a key glucose transporter in reproductive and neurological tissues, 357 
GLUT8 has been found in many tissue types [10]. While some studies have identified 358 
GLUT8 as a multifunctional, insulin-sensitive transporter, it has also been reported as 359 
important in the transport of sugars across intracellular membranes, thus performing 360 
an insulin-independent function [10; 14; 16]. Although GLUT8 could be important in 361 
regulating glucose transport, its role is unknown in horses and not well characterized 362 
during IR in any species. If GLUT8 plays an important role in the maintenance of 363 
cellular metabolism this may account for the presence of GLUT8 in the highly 364 
metabolic lamellar tissue. Interestingly, the up-regulation of lamellar expression of 365 
both GLUTs 8 and 12 in acute laminitis does not occur during subclinical laminitis 366 
associated with the p-GI. It has been shown that epidermal basal cell proliferation 367 
increases during the latter stages of acute, hyperinsulinaemic laminitis development 368 
[31]. If novel GLUT up-regulation occurs in response to increased metabolic demand 369 
and cell proliferation associated with acute laminitis, the lamellar pathology 370 
associated with lower insulin concentrations may not be sufficient to cause an 371 
increase in novel GLUT expression. This suggests that these novel GLUTs may not 372 
play an early, and potentially causative, role in laminitis pathophysiology. However, 373 
protein translation usually lags behind gene expression and therefore qRT-PCR 374 
analyses may reveal early, and hence potentially mechanistic, changes in GLUT8 and 375 
12 expression during the p-GI. Therefore, further work is required to determine if they 376 
a play a pathogenic role in hyperinsulinaemic laminitis or if they are differentially 377 
expressed in the lamellae as a response mechanism to the altered metabolic state 378 
induced by the infusions. 379 
 380 
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In conclusion, our study confirmed that the digital lamellae functions as an insulin-381 
independent tissue, which may indicate that IR is not required for laminitis onset. 382 
Further, there may be a role for the novel GLUTs 8 and 12 in the pathophysiology of 383 
hyperinsulinaemic laminitis and although this appears to be one of disease 384 
progression or maintenance, the exact nature of their role requires further elucidation. 385 
Importantly, these data also illustrate marked differences in GLUT expression 386 
between insulin-sensitive and insulin-independent tissues during metabolic 387 
dysfunction in horses, suggesting that extrapolation of whole body data to the foot 388 
may not be appropriate.  389 
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 402 
Figure Legends 403 
 404 
Figure 1: Insulin and glucose responses to infusions.   405 
Horses were treated with either a prolonged, euglycaemic hyperinsulinaemic clamp 406 
(●, p-EHC, ~46 h, n = 4) or a prolonged-glucose infusion (■, p-GI, 48 h, n = 4) to 407 
induce marked or moderate hyperinsulinaemia respectively. Control horses (▲, n = 7) 408 
were treated with a balanced electrolyte solution for the same period as a matched 409 
treated horse. A: Blood glucose concentration (mmol/L) was increased (p < 0.001) by 410 
the p-GI, but not the p-EHC or the balanced electrolyte solution. B: Serum insulin 411 
concentration (μU/mL) was increased by both the p-EHC (p = 0.007) and the p-GI (p 412 
= 0.002), but not the balanced electrolyte solution. 413 
 414 
Figure 2: Comparison of GLUT protein expression across tissue sites. 415 
The relative protein expression of four GLUT isoforms (1, 4, 8, 12) was compared in 416 
crude membrane fractions of the heart (H), skeletal muscle (SM) and lamellae (L) of 417 
four healthy horses. Results are shown by representative Western blot (above) and 418 
scatter plots with median bar (below). A: GLUT 1 was significantly less in the 419 
skeletal muscle than in the digital lamellae. B: GLUT4 protein expression was 420 
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significantly lower in the digital lamellae than the heart. C-D: Protein expression of 421 
GLUT8 and 12 was similar across all tissue sites.  422 
 423 
Figure 3: Skeletal muscle protein expression of GLUT isoforms during 424 
prolonged, marked hyperinsulinaemia. 425 
Top Panels: Representative Western blot of protein expression in crude membrane 426 
fractions of skeletal muscle from horses treated with a p-EHC compared to controls 427 
(C). GLUT protein expression was normalised to the loading control calsequestrin 428 
(Calsq). A: Median GLUT1 protein content was decreased (p = 0.029) in the p-EHC 429 
group. B: Median GLUT4 protein expression was unchanged in horses treated with a 430 
p-EHC. C-D: Treatment with a p-EHC did not alter the protein expression of GLUT8 431 
and 12.  432 
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 433 
Figure 4: Lamellar GLUT (8 and 12) protein expression was increased during 434 
prolonged hyperinsulinaemia and laminitis. 435 
Top panels: Representative Western blot of protein expression in lamellar crude 436 
membrane fractions from horses treated with a p-EHC compared to controls (C). 437 
GLUT expression was normalised to the loading control actin. A: Median GLUT4 438 
protein expression was unchanged in horses treated with a p-EHC. B: GLUT8 protein 439 
content was increased in horses treated with a p-EHC. C: GLUT12 protein content 440 
was also increased in horses treated with a p-EHC. 441 
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 442 
Figure 5: Lamellar GLUT4 expression during prolonged, marked 443 
hyperinsulinaemia. 444 
A: GLUT4 was barely detectable at the crude membrane surface in horses treated 445 
with a p-EHC, or their matched controls (C), when compared to the positive (+ve) 446 
control tissue. B: GLUT 4 was detectable in total lamellar protein lysates and 447 
treatment with a p-EHC did not alter total lamellar GLUT4 protein content, when 448 
compared with the control group. 449 
 450 
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Figure 6: Lamellar GLUT (1, 8 and 12) protein expression during moderate 451 
endogenous hyperinsulinaemia. 452 
Top panels: Representative Western blot of protein expression in lamellar crude 453 
membrane fractions from horses treated with a p-GI compared to controls (C). GLUT 454 
expression was normalised to the loading control actin. A: Treatment with a p-GI did 455 
not alter GLUT1 protein content when compared with control group. B-C: The 456 
protein expression of the novel GLUT8 and 12 isoforms was not affected by treatment.  457 
 458 
Figure 7: Lamellar GLUT4 expression during moderate endogenous 459 
hyperinsulinaemia. 460 
A: GLUT4 was barely detectable at the crude membrane surface in horses treated 461 
with a p-GI and matched controls (C), when compared to the positive (+ve) control 462 
tissue. B: GLUT 4 was detectable in total lamellar protein lysates and treatment with a 463 
p-GI did not alter total lamellar GLUT4 total protein content, when compared with the 464 
control group. 465 
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